Oncology

More Evidence for Oxaliplatin as Colon Cancer Chemotherapy

Adding oxaliplatin to a standard chemotherapy regimen boosts survival rates for patients with advanced colon cancer, according to a new study that bolsters previous research on the drug by looking at a broader group of patients.
Read more

 http://www.nlm.nih.gov/medlineplus/news/fullstory_121038.htm...

Medline Plus